Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Plastic and Reconstructive Surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Stem Cell Res Ther. 2024 Sep 4;15(1):277. doi: 10.1186/s13287-024-03901-2.
Burn trauma is one of the major causes of morbidity and mortality worldwide. The standard management of burn wounds consists of early debridement, dressing changes, surgical management, and split-thickness skin autografts (STSGs). However, there are limitations for the standard management that inclines us to find alternative treatment approaches, such as innovative cell-based therapies. We aimed to systematically review the different aspects of cell-based treatment approaches for burn wounds in clinical trials.
A systematic search through PubMed, Medline, Embase, and Cochrane Library databases was carried out using a combination of keywords, including "Cell transplantation", "Fibroblast", "Keratinocyte", "Melanocyte", or "Stem Cell" with "Burn", "Burn wound", or "Burn injury". Firstly, titles and abstracts of the studies existing in these databases until "February 2024" were screened. Then, the selected studies were read thoroughly, and considering the inclusion and exclusion criteria, final articles were included in this systematic review. Moreover, a manual search was performed through the reference lists of the included studies to minimize the risk of missing reports.
Overall, 30 clinical trials with 970 patients were included in our study. Considering the type of cells, six studies used keratinocytes, nine used fibroblasts, eight used combined keratinocytes and fibroblasts, one study used combined keratinocytes and melanocytes, five used combined keratinocytes and fibroblasts and melanocytes, and one study used mesenchymal stem cells (MSCs). Evaluation of the preparation type in these studies showed that cultured method was used in 25 trials, and non-cultured method in 5 trials. Also, the graft type of 17 trials was allogeneic, and of 13 other trials was autologous.
Our study showed that employing cell-based therapies for the treatment of burn wounds have significant results in clinical studies and are promising approaches that can be considered as alternative treatments in many cases. However, choosing appropriate cell-based treatment for each burn wound is essential and depends on the situation of each patient.
烧伤创伤是全球发病率和死亡率的主要原因之一。烧伤创面的标准治疗包括早期清创、换药、手术治疗和断层皮片自体移植(STSG)。然而,标准治疗存在局限性,促使我们寻找替代治疗方法,如创新的细胞治疗。我们旨在系统地回顾临床试验中用于烧伤创面的不同细胞治疗方法。
通过组合关键词,包括“细胞移植”、“成纤维细胞”、“角质形成细胞”、“黑素细胞”或“干细胞”与“烧伤”、“烧伤创面”或“烧伤损伤”,在 PubMed、Medline、Embase 和 Cochrane Library 数据库中进行系统搜索。首先,筛选这些数据库中截至“2024 年 2 月”的研究的标题和摘要。然后,仔细阅读选定的研究,并根据纳入和排除标准,将最终文章纳入本系统评价。此外,通过纳入研究的参考文献列表进行了手动搜索,以最大程度地减少遗漏报告的风险。
总的来说,我们的研究纳入了 30 项临床试验,共 970 名患者。考虑到细胞类型,有 6 项研究使用角质形成细胞,9 项研究使用成纤维细胞,8 项研究使用角质形成细胞和成纤维细胞联合,1 项研究使用角质形成细胞和黑素细胞联合,5 项研究使用角质形成细胞、成纤维细胞和黑素细胞联合,1 项研究使用间充质干细胞(MSCs)。这些研究中制剂类型的评估表明,有 25 项试验使用培养方法,5 项试验使用非培养方法。此外,17 项试验的移植物类型为同种异体,13 项其他试验为自体。
我们的研究表明,细胞治疗在烧伤创面治疗方面的临床研究中具有显著效果,是一种很有前途的方法,在许多情况下可以作为替代治疗方法。然而,为每个烧伤创面选择合适的细胞治疗方法至关重要,并且取决于每个患者的情况。